Intuitive Surgical, Inc. develops, manufactures, and markets the da Vinci surgical system and the Ion endoluminal system. The Company's products and related services enable physicians and healthcare providers to access minimally invasive care. The da Vinci surgical system consists of a surgeon console or consoles, a patient-side cart, and a high-performance vision system. The da Vinci products fall into five categories, namely da Vinci surgical systems, da Vinci instruments and accessories, da Vinci Stapling, da Vinci Energy, and da Vinci Vision, including Firefly Fluorescence imaging systems and da Vinci Endoscopes. It also provides a comprehensive suite of systems, learning, and services offerings. The Ion endoluminal system consists of a system cart, a controller, a catheter, and a vision probe. It extends its commercial offerings beyond surgery into diagnostic procedures, enabling minimally invasive biopsies in the lung. Both systems use software, instruments, and accessories.
BörsenkürzelISRG
Name des UnternehmensIntuitive Surgical Inc
IPO-datumJun 13, 2000
CEOMr. David J. Rosa
Anzahl der mitarbeiter15638
WertpapierartOrdinary Share
GeschäftsjahresendeJun 13
Addresse1020 Kifer Road
StadtSUNNYVALE
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl94086
Telefon14085232100
Websitehttps://www.intuitive.com/en-us/about-us/company
BörsenkürzelISRG
IPO-datumJun 13, 2000
CEOMr. David J. Rosa
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten